Fabian Jordan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fabian Jordan has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Patrick Badertscher
Department of Cardiology, University Hospital Basel, Basel, Switzerland; Cardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland
10 shared publications Corinne Isenegger
6 shared publicationsDavid Spreen
6 shared publicationsChristian Sticherling
5 shared publications- Christian Sticherling
Department of Cardiology, University Hospital Basel, University Basel , Basel
5 shared publications Gian Völlmin
Department of Cardiology, University Hospital Basel, University of Basel , Petersgraben 4, Basel 4031
5 shared publications
Latest Publications
- Open Access
- 3 September 2026
- Published by Elsevier in Heart Rhythm
Pulsed-field ablation improves lesion durability despite comparable arrhythmia recurrence after pulmonary vein isolation
- 3 September 2026
- Published by Elsevier in Heart Rhythm
Open AccessPulsed-field ablation improves lesion durability despite comparable arrhythmia recurrence after pulmonary vein isolation
- Open Access
- 2 September 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (9)
Pulsed-field ablation for atrial fibrillation with an extended protocol: the extended PFA dose study
- 2 September 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (9)
Open AccessPulsed-field ablation for atrial fibrillation with an extended protocol: the extended PFA dose study
- Open Access
- 5 June 2026
- Published by Elsevier in Heart Rhythm O2
- Vol. 7 (9) , 1621-1630
Early Arrhythmia Recurrence during the Blanking Period after Pulsed-field Ablation for Atrial Fibrillation
- 5 June 2026
- Published by Elsevier in Heart Rhythm O2
- Vol. 7 (9) , 1621-1630
Open AccessEarly Arrhythmia Recurrence during the Blanking Period after Pulsed-field Ablation for Atrial Fibrillation
- Open Access
- 25 October 2025
- Published by Elsevier in Heart Rhythm O2
- Vol. 7 (1) , 37-45
Sex differences in procedural characteristics, safety, and clinical outcomes of pulsed field ablation for atrial fibrillation
- 25 October 2025
- Published by Elsevier in Heart Rhythm O2
- Vol. 7 (1) , 37-45
Open AccessSex differences in procedural characteristics, safety, and clinical outcomes of pulsed field ablation for atrial fibrillation
- Open Access
- 23 October 2025
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 27 (11)
Anterior mitral isthmus line using pulsed-field ablation with the pentaspline catheter or radiofrequency ablation: procedural characteristics, safety, and mid-term outcomes
Aims: Pulsed-field ablation (PFA) is a non-thermal energy source for pulmonary vein isolation (PVI), offering advantages in safety and procedural efficiency. However, data comparing anterior mitral isthmus line (MIL) ablation using PFA vs. conventional radiofrequency ablation (RFA) are scarce. This study aimed to compare procedural characteristics, safety, and arrhythmia recurrence following PVI with additional anterior MIL ablation using PFA vs. RFA. Methods and results: In this prospective, single-centre analysis from the SWISS-AF-PVI registry, 129 patients (median age 70 years, 40% female) undergoing PVI with anterior MIL ablation were included. Patients received either PFA with a pentaspline catheter (n = 61) or RFA using a 3.5 mm irrigated tip catheter (n = 68). Procedural parameters, complications, and arrhythmia recurrence were assessed over a median follow-up of 327 days. PFA significantly reduced total procedure time (71 vs. 108 min, P < 0.001), LA dwell time (53 vs. 80 min, P < 0.001), and ablation time (27 vs. 50 min, P < 0.001) compared to RFA. MIL ablation with PFA required fewer applications (14; 35 s vs. 473 s RFA, P < 0.001). Arrhythmia-free survival was similar between groups (PFA 48.8% vs. RFA 61.8%, P = 0.34). Among 34 patients undergoing redo procedures, incomplete MIL was found in 53%, with no significant difference between groups. Three major complications occurred. Conclusion: Anterior MIL ablation using PFA is feasible, safe, and more time-efficient than RFA, with comparable mid-term arrhythmia outcomes. However, high rates of MIL reconnection and arrhythmia recurrence highlights the need to improve lesion durability.
- 23 October 2025
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 27 (11)
Open AccessAnterior mitral isthmus line using pulsed-field ablation with the pentaspline catheter or radiofrequency ablation: procedural characteristics, safety, and mid-term outcomes
Aims: Pulsed-field ablation (PFA) is a non-thermal energy source for pulmonary vein isolation (PVI), offering advantages in safety and procedural efficiency. However, data comparing anterior mitral isthmus line (MIL) ablation using PFA vs. conventional radiofrequency ablation (RFA) are scarce. This study aimed to compare procedural characteristics, safety, and arrhythmia recurrence following PVI with additional anterior MIL ablation using PFA vs. RFA. Methods and results: In this prospective, single-centre analysis from the SWISS-AF-PVI registry, 129 patients (median age 70 years, 40% female) undergoing PVI with anterior MIL ablation were included. Patients received either PFA with a pentaspline catheter (n = 61) or RFA using a 3.5 mm irrigated tip catheter (n = 68). Procedural parameters, complications, and arrhythmia recurrence were assessed over a median follow-up of 327 days. PFA significantly reduced total procedure time (71 vs. 108 min, P < 0.001), LA dwell time (53 vs. 80 min, P < 0.001), and ablation time (27 vs. 50 min, P < 0.001) compared to RFA. MIL ablation with PFA required fewer applications (14; 35 s vs. 473 s RFA, P < 0.001). Arrhythmia-free survival was similar between groups (PFA 48.8% vs. RFA 61.8%, P = 0.34). Among 34 patients undergoing redo procedures, incomplete MIL was found in 53%, with no significant difference between groups. Three major complications occurred. Conclusion: Anterior MIL ablation using PFA is feasible, safe, and more time-efficient than RFA, with comparable mid-term arrhythmia outcomes. However, high rates of MIL reconnection and arrhythmia recurrence highlights the need to improve lesion durability.
- Open Access
- 7 October 2025
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 27 (10)
Feasibility and accuracy of wearable electrocardiogram monitoring in adult congenital heart disease
- 7 October 2025
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 27 (10)
Open AccessFeasibility and accuracy of wearable electrocardiogram monitoring in adult congenital heart disease
- Open Access
- 4 August 2025
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 27 (8)
Pulsed-field ablation vs. thermal ablation for paroxysmal atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials
- 4 August 2025
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 27 (8)
Open AccessPulsed-field ablation vs. thermal ablation for paroxysmal atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials
- Open Access
- 22 October 2024
- Published by Elsevier in Heart Rhythm
- Vol. 22 (5) , 1364-1366
Procedural characteristics, safety, and clinical outcomes of pulsed-field ablation for pulmonary vein isolation in patients with a left common pulmonary vein
- 22 October 2024
- Published by Elsevier in Heart Rhythm
- Vol. 22 (5) , 1364-1366
Open AccessProcedural characteristics, safety, and clinical outcomes of pulsed-field ablation for pulmonary vein isolation in patients with a left common pulmonary vein
- Open Access
- 28 June 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (7)
Incidence of acute pericarditis after pulsed-field ablation for the treatment of atrial fibrillation
Pulsed-field ablation (PFA) has emerged as a novel treatment strategy for patients with atrial fibrillation (AF). This new ablation approach utilizes high-energy pulsed electric fields to induce tissue necrosis and cell death. Adequately dosed PFA provides tissue selectivity for myocardium and showed a promising safety profile in previous studies.1–3 While traditional thermal ablation modes such as radiofrequency (RF) energy or cryoballoon (CB) energy showed an acute pericarditis rate of 0.8–10.2%,4 little is known about the incidence of acute pericarditis after PFA. The aim was to assess the incidence of acute pericarditis using PFA for the treatment of AF.
- 28 June 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (7)
Open AccessIncidence of acute pericarditis after pulsed-field ablation for the treatment of atrial fibrillation
Pulsed-field ablation (PFA) has emerged as a novel treatment strategy for patients with atrial fibrillation (AF). This new ablation approach utilizes high-energy pulsed electric fields to induce tissue necrosis and cell death. Adequately dosed PFA provides tissue selectivity for myocardium and showed a promising safety profile in previous studies.1–3 While traditional thermal ablation modes such as radiofrequency (RF) energy or cryoballoon (CB) energy showed an acute pericarditis rate of 0.8–10.2%,4 little is known about the incidence of acute pericarditis after PFA. The aim was to assess the incidence of acute pericarditis using PFA for the treatment of AF.
- Open Access
- 10 April 2024
- Published by Elsevier in Heart Rhythm
- Vol. 21 (8) , 1248-1249
Acute kidney injury after catheter ablation of atrial fibrillation: Comparison between different energy sources
- 10 April 2024
- Published by Elsevier in Heart Rhythm
- Vol. 21 (8) , 1248-1249
Open AccessAcute kidney injury after catheter ablation of atrial fibrillation: Comparison between different energy sources